Matches in SemOpenAlex for { <https://semopenalex.org/work/W2326437353> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2326437353 endingPage "1145" @default.
- W2326437353 startingPage "1145.1" @default.
- W2326437353 abstract "<h3>Background</h3> Anti-TNF therapy with etanercept is, according to clinical trials, effective in approximately 60 - 70% of patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) or psoriatic arthritis (PsA). However, some patients experience adverse events or do not respond to therapy with these drugs leading to a shorter retention. <h3>Objectives</h3> To evaluate and compare retention rates of etanercept in patients with RA, AS or PsA treated with etanercept. <h3>Methods</h3> A total of 606 patients with RA, 230 patients with AS and 157 patients with PsA were consecutively included in observational cohorts. CRP, BSE (RA, AS, PSA), DAS28 (RA, PSA), BASFI and BASDAI (AS) were collected during follow-up. Data with respect to moment and reason of dropout were collected. <h3>Results</h3> Five year follow-up data was available for 350 patients with RA, 180 patients with AS and 108 patients with PsA. The proportion of patients with RA that was still on drug at five years (25%) was significantly (p<0.05) lower than that of patients with AS (43%) and PSA (41%). Disease activity improved significantly (p<0.05) compared to baseline, at six months and remained stable thereafter up to five years, in all three disease. <h3>Conclusions</h3> Disease activity in etanercept treated patients with RA, AS or PsA improved significantly at six months and stabilizes thereafter. The five year retention rate is the highest (>40%) in patients with AS and PSA, whereas only 25% of patients with RA is still on drug five years after start of therapy. <h3>Disclosure of Interest</h3> None declared <h3>DOI</h3> 10.1136/annrheumdis-2014-eular.5199" @default.
- W2326437353 created "2016-06-24" @default.
- W2326437353 creator A5004336957 @default.
- W2326437353 creator A5017243329 @default.
- W2326437353 creator A5018372157 @default.
- W2326437353 creator A5020585867 @default.
- W2326437353 creator A5027096828 @default.
- W2326437353 creator A5035421309 @default.
- W2326437353 creator A5053902058 @default.
- W2326437353 creator A5064804606 @default.
- W2326437353 date "2014-06-01" @default.
- W2326437353 modified "2023-10-06" @default.
- W2326437353 title "AB1043 Etanercept Retention Rates in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis or Psoriatic Arthritis" @default.
- W2326437353 doi "https://doi.org/10.1136/annrheumdis-2014-eular.5199" @default.
- W2326437353 hasPublicationYear "2014" @default.
- W2326437353 type Work @default.
- W2326437353 sameAs 2326437353 @default.
- W2326437353 citedByCount "1" @default.
- W2326437353 countsByYear W23264373532020 @default.
- W2326437353 crossrefType "journal-article" @default.
- W2326437353 hasAuthorship W2326437353A5004336957 @default.
- W2326437353 hasAuthorship W2326437353A5017243329 @default.
- W2326437353 hasAuthorship W2326437353A5018372157 @default.
- W2326437353 hasAuthorship W2326437353A5020585867 @default.
- W2326437353 hasAuthorship W2326437353A5027096828 @default.
- W2326437353 hasAuthorship W2326437353A5035421309 @default.
- W2326437353 hasAuthorship W2326437353A5053902058 @default.
- W2326437353 hasAuthorship W2326437353A5064804606 @default.
- W2326437353 hasConcept C126322002 @default.
- W2326437353 hasConcept C141071460 @default.
- W2326437353 hasConcept C16005928 @default.
- W2326437353 hasConcept C2776260265 @default.
- W2326437353 hasConcept C2777226972 @default.
- W2326437353 hasConcept C2777402515 @default.
- W2326437353 hasConcept C2777453003 @default.
- W2326437353 hasConcept C2777575956 @default.
- W2326437353 hasConcept C2779650986 @default.
- W2326437353 hasConcept C2779722408 @default.
- W2326437353 hasConcept C2780132546 @default.
- W2326437353 hasConcept C2780415856 @default.
- W2326437353 hasConcept C2780564577 @default.
- W2326437353 hasConcept C71924100 @default.
- W2326437353 hasConcept C90924648 @default.
- W2326437353 hasConceptScore W2326437353C126322002 @default.
- W2326437353 hasConceptScore W2326437353C141071460 @default.
- W2326437353 hasConceptScore W2326437353C16005928 @default.
- W2326437353 hasConceptScore W2326437353C2776260265 @default.
- W2326437353 hasConceptScore W2326437353C2777226972 @default.
- W2326437353 hasConceptScore W2326437353C2777402515 @default.
- W2326437353 hasConceptScore W2326437353C2777453003 @default.
- W2326437353 hasConceptScore W2326437353C2777575956 @default.
- W2326437353 hasConceptScore W2326437353C2779650986 @default.
- W2326437353 hasConceptScore W2326437353C2779722408 @default.
- W2326437353 hasConceptScore W2326437353C2780132546 @default.
- W2326437353 hasConceptScore W2326437353C2780415856 @default.
- W2326437353 hasConceptScore W2326437353C2780564577 @default.
- W2326437353 hasConceptScore W2326437353C71924100 @default.
- W2326437353 hasConceptScore W2326437353C90924648 @default.
- W2326437353 hasIssue "Suppl 2" @default.
- W2326437353 hasLocation W23264373531 @default.
- W2326437353 hasOpenAccess W2326437353 @default.
- W2326437353 hasPrimaryLocation W23264373531 @default.
- W2326437353 hasRelatedWork W2011005628 @default.
- W2326437353 hasRelatedWork W2072412214 @default.
- W2326437353 hasRelatedWork W2079436069 @default.
- W2326437353 hasRelatedWork W2147166948 @default.
- W2326437353 hasRelatedWork W2411482347 @default.
- W2326437353 hasRelatedWork W2754289805 @default.
- W2326437353 hasRelatedWork W2782068179 @default.
- W2326437353 hasRelatedWork W4224117766 @default.
- W2326437353 hasRelatedWork W4235629817 @default.
- W2326437353 hasRelatedWork W4298088912 @default.
- W2326437353 hasVolume "73" @default.
- W2326437353 isParatext "false" @default.
- W2326437353 isRetracted "false" @default.
- W2326437353 magId "2326437353" @default.
- W2326437353 workType "article" @default.